Overall Status

Completed (20)

Recruiting (19)

Active, not recruiting (4)

Terminated (4)

Not yet recruiting (3)

Enrolling by invitation (2)

Withdrawn (2)

Unknown status (1)

Phase

phase 3 (18)

phase 2 (11)

phase 2/phase 3 (5)

n/a (4)

phase 1/phase 2 (2)

early phase 1 (1)

phase 1 (1)

Study Documents

Intervention Type

drug (26)

biological (14)

other (12)

behavioral (3)

combination product (1)

diagnostic test (1)

Funder Type

Other (27)

NIH (15)

Industry (13)

Study Type

Interventional (42)

Observational (12)

Observational [Patient Registry] (1)

Covid-19

Showing NaN - NaN of 55

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID19, COVID-19, COVID Trial in United States (Pacritinib, Placebo)

Terminated

COVID19
+2 more

Pacritinib
Placebo

Orange, California
+20 more

Sep 23, 2021

COVID-19 Trial in United States (Acalabrutinib)

Completed

Has Results

COVID-19

Acalabrutinib

Anniston, Alabama
+30 more

Sep 8, 2021

SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

Active, not recruiting

SARS-CoV-2
COVID-19

Sample collection

Birmingham, Alabama
+52 more

Sep 3, 2021

COVID-19, SARS-CoV 2 Trial in Baltimore (Bicalutamide 150 Mg Oral Tablet)

Withdrawn

COVID-19
SARS-CoV 2

Bicalutamide 150 Mg Oral Tablet

Baltimore, Maryland

Johns Hopkins Hospital

Mar 2, 2021

The Evaluation of Hemostasis in Hospitalized COVID-19 Patients

Unknown status

COVID-19

Phlebotomy

Baltimore, Maryland

Sinai Center for Thrombosis Research

Oct 20, 2020